At ZenSynergy Health, our mission is to transform lives by developing innovative drug combinations and wellness experiences that meet the unmet needs in psychiatric disorders. We harness therapeutic preconditioning—a novel approach using repurposed FDA-approved drugs—to prepare the mind for enhanced psychedelic responses, fostering synergy with psychotherapy for improved efficacy and safety. We believe in a holistic path to healing, where standardized mental states lead to strong positive responses, reducing adverse reactions and promoting neurogenesis and lasting mental outlook improvements.

Founded by visionary researcher Mark C. Grier, Ph.D., ZenSynergy Health introduces a dual therapeutic modality that addresses the limitations of traditional psychedelic-assisted therapy. Traditional psychedelic-assisted therapy struggles with diverse patient emotions like anger, sadness, or fear, leading to inconsistent outcomes. Our preconditioning standardizes this to a ‘primed state’ for predictable, positive results. By standardizing patient mental states and enhancing synergy between psychotherapy and psychedelics, we deliver consistent, positive outcomes while minimizing risks.